Acadia Pharmaceuticals to Present at Upcoming Investor Conferences
May 04 2021 - 9:00AM
Business Wire
Acadia Pharmaceuticals Inc. (Nasdaq: ACAD) today announced that
it will participate at the following investor conferences:
BofA Securities 2021 Health Care Conference Fireside Chat
Presentation: Wednesday, May 12, 2021 at 2:45 p.m. Eastern Time
RBC Capital Markets Global Healthcare Conference Fireside
Chat Presentation: Tuesday, May 18, 2021 at 3:05 p.m. Eastern
Time
These conferences will be held virtually. Live webcasts of the
presentations will be accessible on the company’s website,
www.acadia-pharm.com, under the investors section and an archived
recording will be available on the website for approximately one
month following each presentation.
About Acadia Pharmaceuticals
Acadia is trailblazing breakthroughs in neuroscience to elevate
life. For more than 25 years we have been working at the forefront
of healthcare to bring vital solutions to people who need them
most. We developed and commercialized the first and only approved
therapy for hallucinations and delusions associated with
Parkinson’s disease psychosis. Our late-stage development efforts
are focused on dementia-related psychosis, negative symptoms of
schizophrenia and Rett syndrome, and in early-stage clinical
research we are exploring novel approaches to pain management, and
cognition and neuropsychiatric symptoms in central nervous system
disorders. For more information, visit us at www.acadia-pharm.com
and follow us on LinkedIn.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20210504005311/en/
Media Contact: Acadia Pharmaceuticals Inc. Eric Endicott (858)
914-7161 media@acadia-pharm.com
Investor Contact: Acadia Pharmaceuticals Inc. Mark Johnson, CFA
(858) 261-2771 ir@acadia-pharm.com
Acadia Pharmaceuticals (NASDAQ:ACAD)
Historical Stock Chart
From Mar 2024 to Apr 2024
Acadia Pharmaceuticals (NASDAQ:ACAD)
Historical Stock Chart
From Apr 2023 to Apr 2024